Carregant...
New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection
Chronic hepatitis B (CHB) affects over 350 million individuals worldwide and is the most common cause of liver cancer. In the United States, CHB affects at least 2 to 3 million individuals, and current therapies can control the disease but not cure it. There are over 30 new molecules being studied i...
Guardat en:
| Publicat a: | Gastroenterol Hepatol (N Y) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Millennium Medical Publishing
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5495044/ https://ncbi.nlm.nih.gov/pubmed/28690451 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|